Interview with Hiroaki Tanaka at Convergence in Oncology Summit 2018 – Lausanne, Switzerland

Hiroaki Tanaka, Director at Debiopharm, took part in the panel “Innovation in Prevention and Diagnostics”.
COS focuses on disruptive innovative solutions and synergies in the field of oncology.
Don’t miss this year edition! Register at www.convergenceinoncology.ch